raloxifene hydrochloride has been researched along with Fatty Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinoshita, I; Kojima, E; Matsumura, M; Miura, A; Tajima, T; Tashiro, K; Yoshizawa, A | 1 |
| Bracht, A; Campos, LB; Ishii-Iwamoto, EL; Martins-Maciel, ER; Salgueiro-Pagadigorria, CL | 1 |
| Ando, H; Kaneko, S; Komura, T; Matsushita, E; Minato, H; Shimizu, A; Takamura, T; Zen, Y | 1 |
3 other study(ies) available for raloxifene hydrochloride and Fatty Liver
| Article | Year |
|---|---|
[A case of non-alcoholic fatty liver disease (NAFLD) aggravated after treatment with raloxifene].
Topics: Aged; Fatty Liver; Female; Humans; Non-alcoholic Fatty Liver Disease; Osteoporosis; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2011 |
Raloxifene affects fatty acid oxidation in livers from ovariectomized rats by acting as a pro-oxidant agent.
Topics: Acyl Coenzyme A; Acyl-CoA Oxidase; Animals; Chemical and Drug Induced Liver Injury; Disease Progression; Estrogen Replacement Therapy; Fatty Acids; Fatty Liver; Female; Hydrogen Peroxide; Liver; Mitochondria, Liver; Ovariectomy; Oxidants; Oxidation-Reduction; Peroxidase; Peroxisomes; Raloxifene Hydrochloride; Rats; Selective Estrogen Receptor Modulators | 2013 |
Selective estrogen receptor modulator raloxifene-associated aggravation of nonalcoholic steatohepatitis.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Glucose Intolerance; Humans; Insulin Resistance; Liver; Liver Cirrhosis; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Severity of Illness Index | 2007 |